Matches 101 - 150 out of 337 < 1 2 3 4 5 6 7 >
Match Document Document Title
6395768 Uses for indole-3-propionic acids and salts and esters thereof  
The cytotoxic effects of amyloid beta protein on cells are prevented by contacting the cells with an effective amount of an indole-3-propionic acid or a salt or ester thereof. Furthermore, a...
6395764 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agnonists  
This invention involves compounds having the following structure: wherein: a) R 1 is hydrogen; or alkyl; bond (a) is a single or a double bond; b) R 2 and R 3 are each independently selected...
6376531 Method of treatment using deuterium compounds  
The present invention provides organic deuterium compounds which can be therapeutic compounds to treat manic depression. In particular, the present invention relates to deuterated methionine,...
6369109 Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor  
The present invention is, generally, directed to the use of betulinic acid and derivatives thereof for the treatment of neuroectodermal tumors. The present invention is based on the discovery that...
6348486 Methods for modulating bladder function  
This invention provides methods and pharmaceutical compositions for maintaining bladder control or treating urinary incontinence in a mammal utilizing agonists of KCNQ potassium channels, including...
6337344 Indole derivatives as inhibitors or factor Xa  
The present invention relates to the inhibition of blood clotting proteins, and more particularly, to indole derivatives of formula (I), in which R 1a , R 1b , R 1c R 1d , R 2 , R 3 , R 4 and A...
6319918 Substituted indolinones with kinase inhibitory activity  
Substituted indolinones of general formula ##STR1## having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. Exemplary compounds are: ...
6306873 Substituted β-thiocarboxylic acids  
This invention relates to compounds of general formula (I): ##STR1## in which Ar is a group selected from: ##STR2## A1, A2, B, C, D, E, Q1-Q3, R1-R9, Z1 and Z2 are as defined in the disclosure, and...
6302837 Benzothiophene, benzofuran and indole compounds  
A compound selected from those of formula (I): ##STR1## wherein: X represents oxygen, sulphur, or NR 3 wherein R 3 is as defined in the description, Y represents oxygen, sulphur, NR 3 , or...
6300364 Medicinal compositions with cholesterol-lowering effect  
Pharmaceutical compositions having a cholesterol-lowering effect which comprises as the active ingredient a compound having a PPAR (peroxisome proliferator-activated receptor)δ activating effect...
6300365 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia  
The present invention is directed to methods for the treatment of human patients afflicted with fibromyalgia using a non-ergot dopamine receptor D2/D3 agonist. In particular, patients are treated...
6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases  
Compounds of general formula (I) wherein: R 1 is H or optionally joined with R 2 to form a fused ring selected from the group consisting of five to ten membered aryl, heteroaryl or heterocyclyl...
6245761 Indolyl neuropeptide Y receptor antagonists  
This invention provides a series of substituted indoles which are useful in treating or preventing a condition associated with an excess of neuropeptide Y. This invention also provides the novel...
6235769 Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase  
The invention relates in part to a method of preventing or treating an abnormal condition caused by an aberration in the function of the C-RET receptor, and specifically to the treatment and...
6228880 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists  
Compounds having dopaminegic activity are provided, having the formula: ##STR1## wherein R 1 and R 2 are each, independently, hydrogen, C 1 -10 alkyl, or (CH 2 ) m R 4 , wherein R 4 is phenyl...
6221377 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs  
Administration mediums comprising solutions of nitrous oxide in water, alcohols, ethers or oils, and optionally including essential fatty acids or C 1 -C 6 alkyl esters thereof enhance the action...
6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels  
Imido and amido substituted alkanohydroxamic acids reduce the levels of TNFα and inhibit phosphodiesterase in a mammal. A typical embodiment is...
6207686 Endothelin antagonists  
A compound of formula (I), in which: R 1 is lower alkyl, cyclo(lower)alkyl, optionally substituted aryl, optionally substituted heterocyclic group, cyclo(lower)alkyl(lower)alkyl, or...
6174883 3-substituted-2-oxindoles derivatives  
This invention relates to novel 3-substituted-2-oxindole derivatives of the formula ##STR1## and the phamaceutically-accepted salts thereof which are inhibitors of prostaglandin H 2 synthase,...
6169106 Indolinones having kinase inhibitory activity  
The present invention relates to substituted indolinones of general formula ##STR1## wherein R 1 to R 5 , and X are defined as in claim 1, the isomers thereof and the salts thereof, particularly...
6166023 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments  
The invention relates to 1,5- and 3-O-substituted 1H-indazoles of formula (I) ##STR1##
6166055 Benzoisothiazole compounds useful as IL-8 receptor antagonists  
This invention relates to compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). ##STR1##
6160005 Medicament for circadian rhythm sleep disorder  
A preventive and/or therapeutic medicament for circadian rhythm sleep disorders such as jet lag syndrome which comprises as an active ingredient an alkylenedioxybenzene derivative represented by...
6147073 Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors  
A tetralylmethylene-2-oxindole derivative having the following formula (I) ##STR1## wherein one or two of R, R 1 , R 2 and R 3 the said two being the same or different, are selected from: a)...
6133306 Methods of inhibiting neurodegerative diseases  
Methods for inhibiting a nitric oxide-mediated pathological condition and a neurodegenerative disease such as Parkinson's disease, Huntington's disease, Alzheimers's disease, and amyotrophic...
6127404 Tissue selective compounds in the treatment of endometrial proliferation  
The present invention relates to new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment...
6103752 Therapeutic heterocyclic compounds  
Compounds of formula (I) ##STR1## wherein R and R 1 are hydrogen, C 1 -4 alkyl or are linked to form a ring, A is a cycloalkyl or alkyl-cycloalkyl group, n is an integer from 0 to 3, W is...
6090839 Antidiabetic agents  
The instant invention is concerned with aryl and heteroaryl oxyacetic acid type compounds which are useful antidiabetic compounds. Compositions and methods for the use of the compounds in the...
6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them  
6075044 Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases  
The use of certain heterocyclic derivatives for treating parasitic protozoa infections in mammals, in particular bovine trichomoniasis and giardiasis, is disclosed.
6071949 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents  
6066663 Oxidation derivatives of indolylalkylamines and their use as drugs  
The invention relates to derivatives of general formula I ##STR1## The invention also relates to pharmaceutical and cosmetic compositions comprising derivatives of general formula I.
6051593 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors  
The present invention relates to novel 3-(cycloalkanoheteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity...
6028085 Indole derivatives as 5-HT receptor antagonist  
6001866 Method for treating and preventing inflammation and atherosclerosis  
This invention provides a method for treating or preventing inflammation or atherosclerosis in mammals comprising administering an effective amount of a 15-LO inhibitor of Formula I: ##STR1##...
5998463 Glycogen phosphorylase inhibitors  
This invention relates to certain 5-acyl-2-oxo-indole-3-carboxamides useful as inhibitors of glycogen phosphorylase, methods of treating glycogen phosphorylase dependent diseases or conditions with...
5994388 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis  
The present invention relates to inhibition of angiogenesis and the treatment of diseases mediated by angiogenesis. Particularly, the invention relates to the inhibition of neovascularization and...
5985926 Method for inhibiting intracellular viral replication  
There is disclosed a method of preventing or delaying the occurrence of acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus (HIV) seropositive humans by administering an...
5977130 Intimal hypertrophy inhibitors  
The present invention is directed to an intimal hypertrophy inhibitor containing as the active ingredient an oxyindole derivative represented by the following formula (I) or a salt thereof:...
5972988 Method for treatment of chronic bronchitis using indole compounds  
A method is disclosed for the treatment of chronic bronchitis by administering to a mammal in need thereof a therapeutically effective amount of a 1H-indole-3-glyoxylamide compound.
5948808 Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens  
Provided in the present invention are compounds and compositions of substituted indole-3-carbinols and diindolylmethane suitable for treating estrogen-dependent tumors. Also provided are methods of...
5945413 Aspartyl protease inhibitors  
This invention relates to a novel class of compounds that are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of aspartyl protease inhibitors characterized...
5919809 3-substituted-2-oxindole derivatives  
This invention relates to novel 3-substituted-2-oxindole derivatives of the formula ##STR1## and the pharmaceutically-acceptable salts thereof which are inhibitors of prostaglandin H 2 synthase,...
5919790 Hydroxamate inhibitors of interleukin-1β converting enzyme  
The present invention relates to compounds that are inhibitors of interleukin-1β converting enzyme that have the Formula II ##STR1## This invention also relates to a method of treatment of stroke,...
5891902 Indole derivatives  
The present invention relates to indole derivatives represented by formula (I): ##STR1## wherein R 1 and R 2 independently represent hydrogen, lower alkyl, hydroxy, lower alkoxy, halogen,...
5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease  
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease  
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
5880141 Benzylidene-Z-indoline compounds for the treatment of disease  
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
5861426 Nitro compounds of the formula A-X.sub.i -NO.sub.2 and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities  
New compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities, of the general formula: A--X 1 --NO 2 or their salts, wherein: A is R(COX u ) t , wherein...
5859017 Method for inhibiting mast cell and basophil activation  
In a method for treating or preventing allergy or allergic disorders an effective amount of a compound that inhibits intracellular generation of phosphatidic acid and diacylglycerol is...
Matches 101 - 150 out of 337 < 1 2 3 4 5 6 7 >